Pharmaceutical Executive | Publications | Pharmaceutical Executive delivers strategic insights for pharma leaders, covering commercialization, market access, R&D, and leadership to drive success.
Social listening can help medical affairs and medical information teams identify knowledge gaps, strengthen scientific exchange and respond to changing stakeholder needs faster and at greater scale.
Japan launch pricing has become more consequential against the backdrop of the U.S. most-favored-nation (MFN) policy. Japan is included in the reference basket contemplated under ...
Shionogi, Gate Bioscience, and Alector post a trio of new deals, Rajul Jain makes the case for social listening as a medical ...
Shionogi, Gate Bioscience, and Alector post a trio of new deals, Rajul Jain makes the case for social listening as a medical affairs strategic tool, and Doceree's Vijay Adapala argues that HCP ...
Trialbee CEO Matt Walz explores the current impact of AI in delivering practical gains in clinical development and reflects ...
Under terms of the agreement, IntraBio is expected to become a wholly owned subsidiary of Shionogi Inc., Shionogi's New Jersey-based subsidiary. 1 Shionogi Inc. will also acquire all outstanding ...
For years, health care professional (HCP) engagement has rested on a flawed assumption: that more information, delivered ...
Why effective RWD linkage starts with a specific research objective — and how tokenization, clean rooms, and AI make it possible. Real-world data (RWD) is an essential resource for finding insights ...
CORXEL’s Dr. Bo Liang on why GLP-1 therapies are a broader chronic disease platform — not just obesity drugs — with benefits ...
In today’s global marketplace, supply chain readiness is a necessity. As the pharma industry relies more and more on a global supply chain, the impact of disruptions (both regul ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results